@fgomsan@ICUAurologia@ClinicaCEMTRO De momento estoy cogiendo confianza con un sistema bipolar, todavía no tenemos ni un láser suficientemente potente ni morcelador en el hospital, pero aún queda mucho! Sigue haciendo esos vídeos que son muy enriquecedores! Muchas gracias
Breaking news 👉FDA approves 1st oral GnRHR antagonist, Relugolix @Myovant for men with advanced #prostatecancer 👏👏Great news for those with cardiovascular disease and on intermittent ADT desiring rapid testosterone recovery. @OncoAlert Colloquium➡️ https://t.co/pE4WbdcDmS
Super proud of my colleague and my friend Dr Cho, who has co-authored this masterpiece with the giants in Male infertility! @TheLancet@CUHKMedicine#UroSoMe https://t.co/BZcze0Zyi2
Don’t missed our annual MJM virtual meeting today. A webinar on different topics in Urology +
A talk From the foremost expert Florian Thalhammer about Therapeutic options in the management of the symptomatic COVID19 patient.
https://t.co/1mu7WM1Q7b
#liveurology session about medicament therapies for urological tumors with Arbeitskreis urologische Onkologie and Österreichische Gesellshaft für Urologie, a really nice update!
Today we presented our study results on #SoMe#UroSoMe use by residents #AEU20🇪🇸 372 responses🗺 Take a look at the slides and the proportion of residents who use SoMe for their learning/training and most popular platforms @ESRUrology@ResidentesAEU@ResidentesCAU
Movember is stoked to announce the projects selected to take part in the first phase of the @gentlemansride Social Connections Challenge, which is aimed at improving the mental health and wellbeing of motorcyclists.
Read more here: https://t.co/KbruJfVGyV
#B2BGUCancerTriad - Coming up in 5 minutes: Day 2 Welcome Message presented by SPC Members Drs Christopher Evans and Peter Hammerer. Join us online now on #SIUAcademy: https://t.co/DZBTO53ch3 @SiTanguay@pcvblack